Jessica N. Abraham | Designer. Writer. Publicist.

19+ Years of Expertise in Digital Marketing, Social Branding and Public Relations.

  • Home
  • Contact
  • About
  • Home
  • Contact
  • About

No Widgets found in the Sidebar Alt!

  • MedTech, HealthTech, Benzinga, BioSig Technologies, BioPharmaceuticals, Jessica Abraham, Jessica N Abraham,
    Business,  Benzinga,  Biotechnology,  Health,  Technology

    MedTech Company BioSig Technologies Deploys Disruptive Technology To Improve Arrhythmia Care

    April 7, 2022 /

    This article was previously published to Benzinga. Arrhythmia is a heart condition that causes it to beat either too fast, or irregularly. It’s triggered by abnormal electrical activity and affects the heart’s rhythm, leading it to beat out of sync with the rest of the body.  Not every patient experiences arrhythmia in the same way, so it’s sometimes necessary for doctors to provide each patient with a personalized approach to treatment and recovery.  Lifestyle choices and comorbidities, medication, stress and environmental factors can cause the heart to beat out of sync. The world is experiencing an uptick in arrhythmia cases linked to the after effects of COVID-19. Atrial fibrillation (AFib) is the…

    read more
    Jessica N. Abraham Comments Off on MedTech Company BioSig Technologies Deploys Disruptive Technology To Improve Arrhythmia Care

    You May Also Like

    DISC Insights, DISC Personality, Personality Type, Corporate Culture, Employee Relations, Persona, Behavioral Analysis, Coaching, Dominance, Influence, Hiring Cycles, Recruitment, Talent Acquisition, Onboarding, Team Building, Leadership, Workforce Optimization, Corporate Development, Business Development, Business Expansion, Growth, Team Building, Culture, Building Remote Teams, Compliances, Roles, Infrastructure, Differences in Opinion,

    Managing remote teams with DISC

    July 13, 2019
    html, html5, html5 News, html5 gallery, showcase, html5 gallery, website gallery, webstandards, information, web development

    HTML5 Continues to Transform Traditional Print to Scalable Interactive Experiences

    January 15, 2016
    Android,China Wholesale Company,Intel,Kodi,M1 Mini ,PC,MeeGoPad T02,Mini Computer,PC,Technology,Technology News, Windows 10,World's Smallest Android

    Chinavision Releases World’s Smallest Dual Full-Function PC & Android Device

    September 9, 2015
  • Statera Pharmaceuticals treatment for Covid-19 Long-Haulers
    Health,  Benzinga,  Biotechnology,  Business,  Finance

    Groundbreaking Studies to Be Conducted on the Effectiveness of Short and Long-term COVID-19 Therapies Inhibiting the Progression of SARS-CoV-2

    October 28, 2021 /

    Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Statera Biopharma, Inc. (NASDAQ: STAB) recently announced that it has officially received Institutional Review Board (IRB) approval to conduct a Phase 1 pilot study at Loma Linda University Health to evaluate STAT-205 as a treatment in the mitigation of SARS-CoV-2 progression. STAT-205 is a breakthrough immuno-modulator designed to decrease elevated inflammatory responses that are associated with viral infections and inhibit viral replication in human lung cells. Its efficacy was successfully demonstrated during preclinical in vitro studies, where STAT-205 was able to inhibit the replication of…

    read more
    Jessica N. Abraham Comments Off on Groundbreaking Studies to Be Conducted on the Effectiveness of Short and Long-term COVID-19 Therapies Inhibiting the Progression of SARS-CoV-2

    You May Also Like

    Statera Biopharmaceuticals, Groundbreaking Biomedicine Treatment

    Statera BioPharma: The Ticker Formerly Known as CBLI

    September 7, 2021
    Cadiac heart monitoring

    Biotricity Invites Physicians to Join Shared Revenue Opportunity, Provides Clinics with Remote Devices for Improved Monitoring and Diagnosis

    November 11, 2021
    Generation Hemp is a Pure-Play industrial hemp company that focuses on providing sustainability within the industrial hemp sector.

    Is Generation Hemp Now A Leader in Pure-Play Hemp Operations for the Industrial Sector?

    October 28, 2021
  • What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?
    Business,  Benzinga,  Biotechnology,  Finance,  Health

    What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?

    September 8, 2021 /

    Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Statera Biopharma, Inc. (NASDAQ: STAB) — the company formerly known as Cytocom (NASDAQ: CBLI) — recently uplisted to the Nasdaq in lieu of earlier acquisitions involving Cleveland BioLabs and ImQuest Life Sciences, Inc. Last week, the company provided an update on its integration of ImQuest and its plans going forward.  According to Statera, preclinical testing is underway in the screening of second-generation immune therapies using the ImQuest platform for the rapid and accurate assessment of various diseases and how the overall makeup and composition of these diseases interact. The company will look more closely…

    read more
    Jessica N. Abraham Comments Off on What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?

    You May Also Like

    Examiner, The Vault, Florida, Flo-Rida, Beamz, Beamz by Flo Rida, Beamz by FloBeamz, Beamz Interactive, Beats, Beats by Dre, Digital Marketing, DJs, EDM, Electronic Dance Music, Electronica, Electric Daisy, Endorsements, Music, Fort Pierce, Independent Music, Internet Marketing, Live Events, Miami Sound, MIDI, Infrared, Music Creation, Production, Music Production, Music Engineering, Orlando, Prosumer, Audiovisual Gadgets, Technology, Tech News, Recording Equipment, Social Media, Sponsorships, Cross Promotion, Strategic Partnership, Studios, Tallahassee,

    Will “Beamz by Flo Rida” be music to our ears?

    June 18, 2013
    2019,Career Development,Economy,FlexJobs,Globalization,Globalizations,Job Search,Jobs,PayScale.com,Remote Jobs,Remote Work,Resume Academy,Resumes,Study,Survey,The Workforce,Work-Life Balance

    14 of the Most Common Remote Jobs & Annual Salaries, as According to FlexJobs

    January 3, 2019
    2015 SXSW,Apple Devices,Apple’s App Store,Austin,AXS,Best New Startups,California,Cool Technologies,Dance,Danilo Pires,Drums,Florida,Fort Lauderdale,Free,Guitar,Keyboard,Mobile App,Music Collaboration,New Orleans,Saloote,South Florida,Tech News,Technology News,Venture in LA: Startup Trade Mission,Voice

    Saloote creates new mobile app to encourage social music collaboration

    November 22, 2014
  • Statera Biopharmaceuticals, Groundbreaking Biomedicine Treatment
    Health,  Benzinga,  Biotechnology,  Business,  Finance

    Statera BioPharma: The Ticker Formerly Known as CBLI

    September 7, 2021 /

    Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. On September 1, 2021, Cytocom officially became listed as Statera BioPharma, Inc. (NASDAQ: STAB), as it updated its ticker symbol from CLBI to STAB within the Nasdaq markets.  This change in name comes as a natural progression, as the company shifts gears toward placing a more strategic focus on restoring total immune health — including autoimmune and inflammatory diseases, such as fibromyalgia and multiple sclerosis, blood disorders like anemia and lupus, even cancer and various other infectious diseases.  The company began trading as CLBI, last month,…

    read more
    Jessica N. Abraham Comments Off on Statera BioPharma: The Ticker Formerly Known as CBLI

    You May Also Like

    Top Tech Startups, Best Tech Startups, Denver Colorado

    BEST TECH STARTUPS IN DENVER, RANKED

    May 20, 2021
    Smart Buildings, HVAC, Indoor Air Quality, WiFi, Connected Devices, Internet of things, IoT,

    Delphi360™ to Officially Launch, Improve the Work Environment and Change Indoor Air Quality Forever

    September 7, 2021
    Statera Pharmaceuticals treatment for Covid-19 Long-Haulers

    Groundbreaking Studies to Be Conducted on the Effectiveness of Short and Long-term COVID-19 Therapies Inhibiting the Progression of SARS-CoV-2

    October 28, 2021
  • Age-Related Macular Degeneration DRY AMD, Lineage Cell Therapeutics
    Business,  Benzinga,  Finance,  Health,  Regenerative Medicine

    Age-Related Macular Degeneration: What is Dry AMD, and How is Lineage Cell Therapeutics Changing the Game?

    August 11, 2021 /

    Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Age-related macular degeneration (AMD) is a disease originating in the retina, which may worsen over time, according to WebMD. It’s said to be the leading cause of severe, permanent vision loss in people older than 60.  When the macula — the small central portion of the retina — wears down, the light-sensing nerve tissue at the back of the eye begins to deteriorate. While it doesn’t always cause complete blindness, severe vision problems such as loss of central vision may occur. As the condition worsens,…

    read more
    Jessica N. Abraham Comments Off on Age-Related Macular Degeneration: What is Dry AMD, and How is Lineage Cell Therapeutics Changing the Game?

    You May Also Like

    TMC Net, TMCNet, Technology Marketing Corporations, Technology News, Tech News, Mad Marketer, IoT World, NFV Zone, Virtualization, Unified Communications, Call Centers, Contact Centers, Real-Time Communications Web RTC, Call Accounting, Call Recording, Connected Devices, Web Development, Software Development, Mobile Development, Enterprise Solutions,

    BrightPoint Security Enhances Community-Based Threat Intelligence Capabilities

    December 21, 2015
    DISC Personality Types, DISC Theory, Personality Traits, Dominance, Influence, Stability, Compliance, Social Media, Marketing, Internet Marketing, Facebook, LinkedIn, Twitter, Instagram, Reddit, Snapchat, Business, PeopleKeys

    Social Media Activity, Based on Personality Type

    October 24, 2019
    Vision in Sight — Vuzix Outlines Ultra-Sleek Lineup of Smart Glasses, CES 2022 Presence, and Partnerships --- smart glasses, wearables, augmented reality, virtual reality, benzinga, jessica abraham

    Vision in Sight — Vuzix Outlines Ultra-Sleek Lineup of Smart Glasses, CES 2022 Presence, and Partnerships

    January 25, 2022
  • Business
  • Technology
  • Career Development
  • Education
  • Entertainment
  • Fashion
  • Relationships
  • Tips
  • Travel
Ashe Theme by WP Royal.